- TRADE NAMES: Choledyl (Pfizer); Choledyl SA (Warner Chilcott); Oxtriphylline Pediatric; Theobret
- INDICATIONS: Asthma, chronic bronchitis, emphysema, bronchospastic disorders
- CLASS: Bronchodilator
- HALF-LIFE: 1–9 hours in pediatric patients; 3–15 hours in non-smoking adults; 4–5 hours in cigarette smokers
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aminoglutethimide, Carbamazepine, Cimetidine, Ciprofloxacin, Clarithromycin, Disulfiram, Enoxacin, Erythromycin, Estradiol, Estrogens, Febuxostat, Fluvoxamine, Isoproterenol, Methotrexate, Mexiletine, Moricizine, Norfloxacin, Ofloxacin, Phenobarbital, Phenytoin, Propranolol, Rifampin, Sucralfate, Tacrine, Ticlopidine, Verapamil
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
